| Affiliation: | 1. Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Falls Church, Virginia;2. National Reference Centre for Rare Pulmonary Diseases, Department of Respiratory Medicine, Louis Pradel Hospital, Lyon, France;3. Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France;4. Department of Internal Medicine V, Ludwig Maximilian University of Munich, Comprehensive Pneumology Center, Helmholtz Zentrum, Munich, Germany;5. Clinic for Respiratory Medicine, Hannover Medical School, Hannover, Germany;6. Department of Medicine, Weill Cornell Medical College, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York;7. Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia;8. St Vincent''s Hospital, Sydney, Australia;9. Department of Internal Medicine II, Neuwittelsbach Academic Hospital, Ludwig Maximilian University, Munich, Germany;10. Department of Pulmonology, Ege University Hospital, Izmir, Turkey;11. Clinic of Pulmonology, University Hospital Zürich, Zürich, Switzerland;12. Unit for Interstitial Lung Diseases, University Hospitals of Leuven, Leuven, Belgium;13. Bayer Healthcare Company Ltd., Beijing, China;14. Department of Radiology, University of Munich, Munich, Germany;15. Bayer AG, Berlin, Germany;p. Chrestos Concept GmbH & Co. KG, Essen, Germany;q. Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom |
